MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Attentional Intervention to Improve Cognition and Gait in Parkinson’s Disease: Side of Onset Effects

    A. Cronin-Golomb, O. Barthelemy, A. Marin, B. Davis, S. Alshuaib, T. Ellis, J. Degutis (Boston, MA, USA)

    Objective: To establish whether home-based computerized attentional training would improve cognition, gait, and function in Parkinson’s disease (PD). Background: Impairments in cognition and gait are…
  • 2019 International Congress

    Evaluation of Clinical Peculiarities of Violations of Vertical Vision in Patients with Parkinson’s Disease

    M. Salokhiddinov, D. Akramova (Tashkent, Uzbekistan)

    Objective: To study vertical oculomotor reflexes(VOR) and the state of the functional system "eyelid" in patients with Parkinson's disease. Background: Parkinson's disease (PD) is a common…
  • 2019 International Congress

    Rapidly progressive cognitive decline and hemi-dystonia due to anti-neuronal surface antibodies

    F. Rolim, L. Mendes, P. Braga Neto, R. Sampaio, G. Ferreira, P. Nóbrega, V. Mesquita, F. Maia (Fortaleza, Brazil)

    Objective: To describe a case of marked asymmetric coarse tremor and dystonia in patient diagnosed with anti-NMDAR encephalitis. Background: Anti-NMDAR encephalitis has complex and heterogeneous…
  • 2019 International Congress

    Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients

    S. Becker, C. Pauly, M. Lawton, G. Hipp, F. Bowring, P. Sulzer, M. Hu, R. Krüger, I. Liepelt-Scarfone (Tübingen, Germany)

    Objective: To validate novel scores assessing cognitive-driven activity of daily living (ADL) dysfunction in a large, international pooled non-demented Parkinson’s disease (PD) cohort. Background: The…
  • 2019 International Congress

    Self-report of cognitive functional abilities is inaccurate in PD-MCI and PDD

    S. Holden, L. Medina, A. Simpson, B. Kluger (Aurora, CO, USA)

    Objective: Evaluate concordance between self-reported and performance-based measures of cognitive functional abilities in PD by cognitive class. Background: PD-specific cognitive functional questionnaires, the Penn Daily…
  • 2019 International Congress

    Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort

    A. Luca, R. Monastero, G. Donzuso, R. Baschi, C. Cicero, C. Terravecchia, A. Salerno, M. Zuccarello, M. Davì, V. Restivo, G. Mostile, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: To identify modifiable vascular risk factors (VRFs) associated with cognitive decline in early PD. Background: The importance of the early identification of modifiable risk…
  • 2019 International Congress

    Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.

    TZ. Ren, K. Nie, LJ. Wang (Guangzhou, China)

    Objective: The aim of this study was to compare the structure of gut microbiota and short-chain fatty acid(SCFAs) in PD with mild cognitive impairment (PD-MCI),…
  • 2019 International Congress

    Neuropsychological differences between patients with Parkinson’s Disease and Essential Tremor

    M. Zorn, K. Duff, J. Rolston, C. Aquino, J. Ballard, P. Moretti (Salt Lake City, UT, USA)

    Objective: Investigate neuropsychological differences between Parkinson's disease (PD) and essential tremor (ET) patients presenting for evaluation for Deep Brain Stimulation (DBS) surgery. Background: Although patients with PD and ET have…
  • 2019 International Congress

    Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease

    H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

    Objective: To study the neural connections between orbitofrontal cortex (OFC) and olfactory cortex and analyze their consistency ranging from control group to Parkinson’s Disease (PD)…
  • 2019 International Congress

    The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study

    H. Wilson, G. Dervenoulas, G. Pagano, A. Chandra, F. Niccolini, M. Esposito, R. Gunn, L. Ricciardi, E. Rabiner, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate the role of synaptic vesicle glycoprotein 2A (SV2A) in Parkinson’s disease dementia (PDD) and Dementia with Lewy bodies (DLB) using…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley